All Stories

  1. A magnetogenetic atlas of cytoskeleton-resolved gene regulation in mesenchymal stem cells
  2. Effect of a Constant Magnetic Field on Cell Morphology and Migration Mediated by Cytoskeleton-Bound Magnetic Nanoparticles
  3. Synthesis of Conjugates of PEG-RGD Derivatives with Fe3O4 Magnetic Nanoparticles for Cell Labelling
  4. Immobilization of doxorubicin on Fe3O4 magnetic nanoparticles modified with iron and silicon glycerolates
  5. Nano-bio interaction of magnetic nanoparticles with cells in a tumor at the single-cell level
  6. Effect of a constant magnetic field on morphology and motility of cell with cytoskeleton-associated magnetic nanoparticles
  7. Synthesis of closo- and nido-carborane derivatives of the KRGD peptide
  8. Nanocomposite material based on Fe3O4 magnetic nanoparticles modified with iron and silicon glycerolates: synthesis and characterization
  9. Magnetic Nanocomposite Materials Based on Fe3O4 Nanoparticles with Iron and Silica Glycerolates Shell: Synthesis and Characterization
  10. Synthesis of Novel Carborane-Containing Derivatives of RGD Peptide
  11. Features of doxorubicin adsorption on Fe3O4 magnetic nanoparticles coated with SiO2 or SiO2/aminopropylsilane
  12. Removal of microplastics from water by using magnetic sedimentation
  13. Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles
  14. Effect of the Silica–Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption
  15. Magnetic-Responsive Doxorubicin-Containing Materials Based on Fe3O4 Nanoparticles with a SiO2/PEG Shell and Study of Their Effects on Cancer Cell Lines
  16. Comparative study of L-Lys modification of gas-condensation and chemically obtained magnetic Fe3O4 nanoparticles for cell labelling
  17. Synthesis of fluorescent GRGD peptide derivatives
  18. Individual iron(iii) glycerolate: synthesis and characterisation
  19. Smart Design of a pH-Responsive System Based on pHLIP-Modified Magnetite Nanoparticles for Tumor MRI
  20. Modification of chemically and physically obtained Fe3O4 magnetic nanoparticles with l-Lys for cell labeling
  21. Design of SiO2/aminopropylsilane-modified magnetic Fe3O4 nanoparticles for doxorubicin immobilization
  22. Silica coating of Fe3O4 magnetic nanoparticles with PMIDA assistance to increase the surface area and enhance peptide immobilization efficiency
  23. Synthesis of Fe@C nanoparticles containing sulfo groups on their surfaces and study of their aggregation behavior in aqueous media
  24. Modification of Fe3O4 magnetic nanoparticles with a GRGD peptide
  25. Variation in tumor pH affects pH-triggered delivery of peptide-modified magnetic nanoparticles
  26. Modification of human monocytes and macrophages by magnetic nanoparticles in vitro for cell-based delivery
  27. L-Lysine-modified Fe3O4 nanoparticles for magnetic cell labeling
  28. pH-triggered delivery of magnetic nanoparticles depends on tumor volume
  29. Factors Affecting the Labeling of NIH 3T3 Cells with Magnetic Nanoparticles
  30. Supporting data and methods for the characterization of iron oxide nanoparticles conjugated with pH-(low)-insertion peptide, testing their cytotoxicity and analyses of biodistribution in SCID mice bearing MDA-MB231 tumor
  31. NMR Relaxometry at Quantification of the Captured Magnetic Nanoparticles by Cells
  32. Synthesis of glutaryl-containing derivatives of GRGD and KRGD peptides
  33. Immobilization of a pH-low insertion peptide onto SiO2/aminosilane-coated magnetite nanoparticles
  34. Synthesis and Quantification of 2-(Diethylamino)-N-(2-methylphenyl)acetamide Nitrate
  35. Synthesis of nanocomposite with a core—shell structure based on Fe3O4 magnetic nanoparticles and iron glycerolate
  36. Immobilization of fluorescent protein TagGFP2 on Fe3O4-based magnetic nanoparticles
  37. Magnetic Properties and Structure of TiO2-Mn (0.73%) Nanopowders: the Effects of Electron Irradiation and Vacuum Annealing
  38. Modifying the surface of cerium oxide nanopowders produced by physical method
  39. Immobilization of PMIDA on Fe 3 O 4 magnetic nanoparticles surface: Mechanism of bonding
  40. PMIDA-Modified Fe3O4 Magnetic Nanoparticles: Synthesis and Application for Liver MRI
  41. Murine and human hematopoietic progenitor cultures grown on stromal layers expressing Notch ligands
  42. MNPs for contrast-enhanced MRI
  43. Magnetic stromal layers for enhanced and unbiased recovery of co-cultured hematopoietic cells
  44. Synthesis of hybrid nanoparticles based on magnetic Fe3O4 nanoparticles and luminescent CdS nanoparticles
  45. The design of hybrid materials based on magnetic Fe3O4 nanoparticles and luminescent CdS nanoparticles for cell visualization
  46. pHLIP-modified magnetic nanoparticles for targeting acidic diseased tissue
  47. Correction: pHLIP-modified magnetic nanoparticles for targeting acidic diseased tissue
  48. Hemozoin “knobs” in Opisthorchis felineus infected liver
  49. Synthesis of enantiomers of N-(2-aminopurin-6-yl)amino acids
  50. Quantitative Determination of 3-Aminopropylsilane on the Surface of FE3O4 Nanoparticles by Attenuated Total Reflection Infrared Spectroscopy
  51. Synthesis of derivatives of the RGD peptide with the residues of glutaric and adipic acids
  52. Functionalization of Fe3O4 magnetic nanoparticles with RGD peptide derivatives
  53. Novel synthetic routes to N-(2-amino-9H-purin-6-yl)-substituted amino acids
  54. The use of 3-mercaptopropyltrimethoxysilane for stabilization of luminescent cadmium sulfide nanoparticles
  55. Covalent Surface Modification of Fe3O4 Magnetic Nanoparticles with Alkoxy Silanes and Amino Acids
  56. Surface modification of Fe3O4 magnetic nanoparticles with (S)-naproxen
  57. Synthesis of novel carboranyl derivatives of α-amino acids
  58. Determination of enantiomeric purity of 1-substituted 3-amino-1,2-dicarba-closo-dodecaboranes by HPLC on chiral stationary phases
  59. Synthesis of N-[(3-Amino-1,2-dicarba-closo-dodecaboran-1-yl)acetyl] Derivatives of α-Amino Acids
  60. Acidic hydrolysis of N-acyl-1-substituted 3-amino-1,2-dicarba-closo-dodecaboranes
  61. Study of the effect of the nature of the side chain in esters of  -amino acids on the diastereoselectivity of condensation with 5(4H)-oxazolone in the synthesis of dipeptides with N-terminal N-acetylphenylalanine
  62. Kinetic resolution of 1-methyl- and 1-phenyl-3-amino-1,2-dicarba-closo-dodecaboranes via acylation with chiral acyl chlorides
  63. Efficient large (ca. 40 g) laboratory scale preparation of (S)- and (R)-valine tert-butyl esters